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Editorial on the Research Topic
Immune-Modulatory Effects of Vitamin D
Vitamin D plays an essential role in bone development. However, recent studies are beginning
to uncover its role as a modulator of the immune system (1). Several reports have shown
associations between vitamin D deficiency (2) and the incidence as well as the severity of chronic
inflammatory diseases such as cardiovascular disease (3, 4), inflammatory bowel disease (5), asthma
(6), and chronic obstructive pulmonary disease (COPD) (7). Consistent with this, vitamin D
supplementations have been shown to reduce the severity of and inflammation markers in chronic
inflammatory diseases (8). At the molecular level, the hormonally active form of vitamin D (α1,25
dihydroxyvitamin D3) regulates the expression of vitamin D responsive genes that can lead to
differential regulation of signaling pathways in immune cells. For example, vitamin D positively
regulates iron homeostasis and erythropoiesis via the iron-hepcidin-ferroportin axis (9). Vitamin
D deficiency is highly prevalent world-wide including countries with abundance of sunshine (10).
Singh et al. reviewed the causes of vitamin D deficiency where they dissected the complex impact
of genetic predisposition, gut microbiota, and immune system. In this review, authors examined
GWAS database (11) and listed genes variants with SNPs that associate with risk of vitamin D
deficiency. These alleles are common in vitamin D receptor (VDR) and vitamin D binding protein
(VDPB). Since gut microbiota plays a crucial role in nutrients and vitamins production, absorption
and degradation, authors also highlighted the role of vitamin D metabolism and VDR is regulating
host-gut microbiota interactions.
At the cellular level, vitamin D exerts anti-inflammatory effects on immune cells that express
the vitamin D receptor (VDR) such as monocytes, macrophages, and T lymphocytes, which
in turn shapes the immune response during the onset of inflammation and infection and
following vaccination. Vitamin D exerts anti-inflammatory effects by reducing pro-inflammatory
cytokines production from macrophages and T cells (12, 13). Carlberg eloquently demonstrated
that vitamin D/VDR signaling impacts chromatin modeling leading to significant modification
of human monocytes epigenome during perturbation, consequently reducing cytokine release
and modulating trained innate immunity. The immune modulatory effects of vitamin D include
reduction in inflammatory cytokines release such as IL-1β, which is induced via inflammasome
activation. Rao et al. showed that VDR inhibited NALP3-inflammasome activation leading to
reduction in IL-1β release. To confirm the inhibitory effect of VDR on NLP3 inflammasome
activation, authors used VDR-deficient mice and showed that IL-1β release was significantly
reduced in vivo confirming that VDR inhibited NALP3 inflammasome activation. Vitamin D
deficiency is associated with bone pain in particular and chronic disease pain in general (12,
14). The proposed mechanisms by which Vitamin D/VDR signaling modulate pain sensation
is reviewed by Habib et al.. Authors delineate vitamin D/VDR interactions with pain sensing
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pathways including dorsal root ganglion (DRG) neurons, nerve
growth factor (NGF), epidermal growth factor receptor (EGFR),
glial-derived neurotrophic factor (GDNF), and opioid receptors.
Sufficient levels of vitamin D have been shown to regulate
T cell proliferation by controlling T cell antigen receptor and
T cell activation as well as enhancing the phagocytic activity
of macrophages (12, 14). The immune suppressive effects of
regulatory T cells (T-reg) in controlling inflammation and
preventing autoimmunity is well-established. Maternal immune
tolerance to fetus is also integral to successful pregnancy.
Vitamin D deficiency is quite common in pregnancy which
has been associated with adverse outcomes. Cyprian et al.
reviewed the consequences of vitamin D deficiency during
pregnancy and detailed the role of T-regs in mitigating
pregnancy loss and adverse events such as preeclampsia.
Further, Vitamin D is shown to play an important role
in modulating graft-vs-host disease (GvHD) by balancing
immune responses. Flamann et al. described the role of
vitamin D in inducing immune suppressive T regs and
balancing immune responses in allogeneic hematopoietic
stem cell transplantation. The immune modulatory effects
of vitamin D increased immune tolerance and enhanced
anti-tumor activity.
In cases of autoimmune diseases, low vitamin D levels are
associated with increased B cell proliferation and autoantibody
production. Low vitamin D levels have also been associated
with the incidence of autoimmune diseases such as Rheumatoid
Arthritis (RA), Multiple Sclerosis (MS), and Systemic Lupus
Erythematosus (SLE) (15). A systematic review by Islam et al. on
the immunomodulatory effects of diet and nutrients in Systemic
Lupus Erythematosus (SLE) presented the beneficial effect of
vitamin D supplementation such as alleviating fatigue. Meta-
analysis studies showed that SLE patients have significantly
lower vitamin D levels compared to healthy participants. In
human and animal studies of SLE, vitamin D is shown to
inhibit cytokines such as IL-10, IL-17, IFN-γ, and modulate
cellular proliferation of B-cells, Th1, Th17, CD4+ T cells.
Therefore, vitamin D exerts various immune modulatory effects
during autoimmune diseases. Another example of autoimmune
diseases is Type 1 diabetes mellitus (T1DM) where insulin
producing pancreatic β-cells are attacked by T cell-mediated
autoimmunity (12, 16). Stem cell transplantation has emerged
as regenerative treatment for T1DM as it possess immune
suppressive potential. A clinical trial (NCT03920397) conducted
by Araujo et al. on the effect of vitamin D treatment with
allogenic adipose tissue-derived stromal/stem cells (ASCs) in
13 patients with recent onset of T1DM. One group received
ASC and vitamin D (cholecalciferol 2,000 UI/day) for 3
months while the second group received standard insulin
therapy. They observed that allogenic ASC and vitamin D
therapy lead to reduced insulin requirement and more stable
C peptide.
Low vitamin D status has been shown to be a risk factor
for infectious diseases (17, 18). During infections such as
Tuberculosis (TB), vitamin D induces the expression of
cathelicidin (LL-37), a host defense peptide that enhances
the bactericidal activity of immune cells like macrophages,
thereby limiting the growth of mycobacteria that causes
TB (18). Furthermore, LL-37 exerts anti-inflammatory
effects via its ability to neutralize bacterial molecules like
endotoxins and capsular polysaccharides that activate TLR
signaling pathways, consequently inhibiting the release of
pro-inflammatory mediators from macrophages. In this special
topic several research papers investigated the role of vitamin
D in infection outcomes. Muvva et al. investigated the effect
of vitamin D on controlling intracellular Mycobacterium
tuberculosis (Mtb) infection in human monocytes-derived
macrophages. They showed that vitamin D treatment resulted
in an appropriate macrophage polarization M1/M2 phenotype
with enhanced expression of antimicrobial LL-37 and anti-
inflammatory cytokine IL-10 but reduced expression of
the immune suppressive enzyme IDO. This in vitro study
provides evidence to the immune modulatory effects of
vitamin D in controlling Mtb infection. Similarly, LL-37 is
shown to control Leishmania parasitic infections in human.
Crauwels et al. observed increased expression of LL-37 in skin
biopsies from cutaneous leishmaniasis. They demonstrated that
recombinant LL-37 reduced Leishmania parasite viability in
a dose-dependent manner. Accordingly, they investigated the
effect of vitamin D treatment on human monocytic-derived
macrophages and documented that LL-37 mediated Leishmania
restriction in macrophages. Vitamin D role in controlling
infection is also demonstrated in acute enterocolitis. Mousavi
et al. used an animal model to investigate the beneficial
effects of vitamin D on preserving intestinal barrier and
exerting anti-pathogenic effects during Campylobacter jejuni
infection. They reported that preclinical administration of
vitamin D ameliorated acute campylobacteriosis in mice
model by reducing bacterial colonization and translocation,
restoring intestinal epithelial cells regeneration and dampening
inflammatory responses.
Vitamin D deficiency increases the risk of bacterial and
viral infections (17). The immune modulatory effects of
vitamin D during bacterial infections seem to vary from
those effects during viral infections. In this regards, Anderson
et al. observed the differential effects of vitamin D on
induced inflammatory responses in primary human peripheral
mononuclear cells (PBMC) during bacterial pneumococcal
infection alone, respiratory syncytial viral (RSV) infection or co-
infection. They showed that vitaminD exerted anti-inflammatory
effects by reducing Th17 inflammatory cell expression and
cytokines during pneumococcal infection alone and RSV alone
but not during co-infection with RSV.
Genetic predisposition plays a role in host susceptibility
to infections (19). Similarly, polymorphism in genes involved
in vitamin D metabolism and function such as VDR impacts
host susceptibility to infections. Pepineli et al. evaluated four
genetic variants of VDR in the Leprosy immune pathogenesis
in Brazil. They investigated a cohort of 404 leprosy patients
in comparison to 432 control individuals without disease.
Although no association is identified in VDR polymorphism
genetic frequency between patients with active clinical leprosy
and controls, they observed bAt haplotype to confer protection
from leprosy. Taken together, data from original research paper,
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clinical trial, systematic analysis, and reviews included herein
provide compelling evidence to the immune modulatory effects
of vitamin D. Therefore, vitamin D deficiency should be treated
to gain the extra skeletal beneficial effects on the immune system
in health and disease.
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